Zobrazeno 1 - 10
of 124
pro vyhledávání: '"Michiyuki Usami"'
Autor:
Tadaichi Kitamura, Osamu Ogawa, Yoshihiko Hirao, Michiyuki Usami, Hideyuki Akaza, Shiro Hinotsu, Masaru Murai, Kazuhiro Suzuki, Seiji Naito, Taiji Tsukamoto, Mikio Namiki
Publikováno v:
Prostate International, Vol 1, Iss 2, Pp 81-88 (2013)
Prostate International
Prostate International
Purpose To determine the influence of maximal androgen blockade (MAB) and non-MAB hormonal therapy with an luteinizing hormone releasing hormone (LHRH) analog on overall survival of prostate cancer patients in the Japan Study Group of Prostate Cancer
Autor:
Jin Li, Yanfei Liu, Masahiro Nii, Helen Tomkinson, Lennie Wu, Malcolm R Ranson, John Kemp, Yunxia Zuo, Jun Qian, Michiyuki Usami
Publikováno v:
Cancer Chemotherapy and Pharmacology. 70:57-63
The endothelin axis and the endothelin A (ETA) receptor have been implicated in tumor development and bone metastasis. This study aimed to investigate the pharmacokinetic (PK) and safety profiles of the specific ETA receptor antagonist, zibotentan, i
Autor:
Seiichiro Ozono, Yutaka Horiguchi, Yoshihiko Hirao, Seiji Naito, Tomoyasu Tsushima, Kyoichi Tomita, Hirofumi Koga, Hideyuki Akaza, Michiyuki Usami
Publikováno v:
International Journal of Urology. 17:759-766
Objectives: We carried out a prospective, randomized, controlled trial to investigate the efficacy and safety of both induction and maintenance therapy with intravesical instillation of bacillus Calmette-Guerin (BCG) for high-risk non-muscle invasive
Publikováno v:
Journal of Urology. 183:952-957
Pathological assessment of radical prostatectomy specimens has not been uniform among pathologists. We investigated interobserver variability of radical prostatectomy specimen reviews between local and central pathologists.We collated data from 50 in
Publikováno v:
Cancer Chemotherapy and Pharmacology. 66:1065-1070
S-1, an oral anticancer agent, contains tegafur (FT), 5-chloro-2,4-dihydroxypyridine (CDHP), and potassium oxonate (Oxo) at a molar ratio of FT:CDHP:Oxo = 1:0.4:1. The aim of this trial was to investigate the efficacy and safety of S-1 in Japanese pa
Autor:
Hiroyuki Fujimoto, Michiyuki Usami, Taiji Tsukamoto, Hideyuki Akaza, Mikio Namiki, Mikio Kobayashi, Isao Ikemoto, Seiji Naito
Publikováno v:
Oncology. 78:323-328
Objectives: This study was conducted to evaluate the efficacy and safety of S-1, an oral fluoropyrimidine derivative, in Japanese patients with castration-resistant prostate cancer (CRPC). The primary endpoint was prostate-specific antigen (PSA) resp
Autor:
Yoshiko Aoyagi, Manoop S. Bhutani, Francesco Paolo D'Armiento, Jian-Zhong Di, Maurie Markman, Hiroto Kayashima, Nikolaos Androulakis, Toshiaki Watanabe, J. Legakis, Georgia Milaki, Jørn G. Stemland, Jennifer J. Knox, Jeffrey H. Lee, Julio Hajdenberg, Alfonso De Stefano, Marcella Giordano, John V. Brown, Keisuke Nakamura, Seiji Naito, Kazuyoshi Motomura, Isao Ikemoto, Kenzo Shimazu, Anna Crispo, Tamila L. Kindwall-Keller, Norikazu Masuda, Bram H. Goldstein, Kenichi Taguchi, Hajime Shibuya, J. Koutantos, Carsten Nieder, Eric M. Rohren, Brendan D. Curti, Yoshihisa Sakaguchi, J. Stathopoulos, Maria D'Armiento, John D. Hainsworth, Taiji Tsukamoto, Jodi J. Prochaska, S. Batzios, Pin Zhang, Ronald M. Bukowski, Hiroshi Yamamoto, Yuichi Takatsuka, Harry A. Drabkin, Qi Zheng, Ai-Zhong Wang, Eisuke Adachi, David F. McDermott, Mikio Namiki, Niki Karachaliou, Zhongxing Liao, Hideo Inaji, Sabino De Placido, Santosh B. Murthy, Chenghua Xia, Nikolaos Vardakis, Lisa N. Abaid, D. Trafalis, Mark Kozloff, Srikrishna V. Patnana, Christopher W. Ryan, Tetsuya Taguchi, Stephen G. Swisher, Yasushi Toh, Janice P. Dutcher, Fumine Tsukamoto, Nikolaos Ziras, Yu Wang, Wayne L. Hofstetter, Astrid Dalhaug, Yoshihiko Maehara, Wilson H. Miller, Lianchun Xiao, John P. Micha, Takeshi Okamura, Homer A. Macapinlac, Hiroyuki Fujimoto, Jaffer A. Ajani, Kazuyuki Wakita, Stefano Pepe, A. Armakolas, Fairooz F. Kabbinavar, Shinzaburo Noguchi, Axel Grothey, Michiyuki Usami, Wei Dong, Guanshan Zhu, Xuemei Wang, Takahiro Nakayama, Jordan Berlin, Wen-Ye Gu, Robert A. Figlin, Lisa Cupit, Jan Norum, Luis Chu, G.P. Stathopoulos, Vassilis Georgoulias, Lifang Hou, Hisae Iinuma, Kohri Yoneda, Akinobu Taketomi, Ken Shirabe, Antonia Kalykaki, Zhong-Zheng Zhu, Sarita Dubey, Charles A. Henderson, L. Cannella, Mark A. Rettenmaier, Mark Ashby, Amy P. Sing, Norifumi Harimoto, Janine K. Cataldo, Takashi Nomura, Marc S. Ernstoff, Walter M. Stadler, Takashi Morimoto, Andrew J. Gawron, Wen-Ming Cong, Aris Polyzos, Nikolaos Kentepozidis, Patrick J. Flynn, Chiara Carlomagno, Hideyuki Akaza, Mikio Kobayashi, C. Batziou, Stylianos Kakolyris, Sebastien J. Hotte, Yoshiaki Nakano
Publikováno v:
Oncology. 78:I-IV
Autor:
Taizo Hiraishi, Michiyuki Usami, Noriko Kanbara, Masahiro Izumi, Norio Meguro, Nobuhisa Awata, Hironobu Tanigami, Ryusuke Ueda, Yoshihiko Kishi, Hiroshi Takami, Masahiko Nishida, Toshiaki Kinouchi
Publikováno v:
Japanese journal of extra-corporeal technology. 35:23-28
要旨下大静脈(IVC)浸潤を伴う癌に対する切除とIVC再建術では、安定した循環動態の確保が困難であり、至適補助手段はいまだ確立されていない。我々はIVC浸潤を伴う腎癌に対する癌切除
Autor:
Hidetoshi Ehara, Michiyuki Usami, Kazuto Ito, Hideki Origasa, Hideyuki Akaza, Mikio Namiki, Satoshi Ueno, Takashi Fukagai, Atsushi Mizokami, Hiroyuki Kinbara
Publikováno v:
BJU International. 99:6-9
Data from the Japanese Urological Society showed that, in Japan, almost half of patients with localized prostate cancer are treated with hormone therapy (HT), regardless of disease stage, and that radiation therapy (RT) is also widely used to treat h
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 41(13)
The efficacy of combined androgen blockade therapy consisting of flutamide, a nonsteroidal antiandrogen, plus an LH-RH agonist (F-CAB) was investigated in Japanese patients with untreated advanced prostate cancer (clinical stage D). The primary endpo